News
Important Only
Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc IGMS.O:IGM BIOSCIENCES ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $1.247 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHTIGM BIOSCIENCES INC - CONCENTRA TO BUY IGM BIOSCIENCES FOR $1.247 PER SHAREReuters
Tue, Jul 1
Limbach Acquires Pioneer Power
July 1 (Reuters) - Limbach Holdings Inc LMB.O:LIMBACH ACQUIRES PIONEER POWERLIMBACH HOLDINGS INC - BUYS PIONEER POWER FOR $66.1 MILLIONLIMBACH HOLDINGS INC - EXPANDS REVOLVING CREDIT FACILITY TO $100 MILLIONLIMBACH HOLDINGS INC - EXPECTS INCREMENTAL IMPACT ON REVENUE AND EBITDA IN 2025LIMBACH HOLDIN...Reuters
Tue, Jul 1
Sonic Automotive Becomes The Largest Jaguar Land Rover Retailer In The U.S.
July 1 (Reuters) - Sonic Automotive Inc SAH.N:SONIC AUTOMOTIVE BECOMES THE LARGEST JAGUAR LAND ROVER RETAILER IN THE U.S.SONIC AUTOMOTIVE INC - BUYS FOUR JAGUAR LAND ROVER DEALERSHIPS IN CALIFORNIASONIC AUTOMOTIVE INC - DEAL EXPECTED TO ADD $500 MILLION IN ANNUAL REVENUEReuters
Tue, Jul 1
Emerald AI Launches With $24.5m Seed Round To Transform AI Data Centers Into Grid Allies
July 1 (Reuters) - NVIDIA Corp NVDA.O:EMERALD AI LAUNCHES WITH $24.5M SEED ROUND TO TRANSFORM AI DATA CENTERS INTO GRID ALLIESEMERALD AI - FUNDING LED BY RADICAL VENTURES, WITH PARTICIPATION FROM NVENTURES (NVIDIA'S VENTURE CAPITAL ARM), AMPLO, CRV, AND NEOTRIBEReuters
Tue, Jul 1
DIARY-Political and General News Events from July 1
July 1 (Reuters) - For other diaries, please see:Political and General News POL/DIARYTop Economic Events M/DIARYEmerging Markets Economic Events EMRG/DIARYGovernment Debt Auctions D/DIARYU.S. Federal Reserve FED/DIARYToday in Washington WASH/DIARY ---------...Reuters
Tue, Jul 1
CANADA RESEARCH ROUNDUP-Bombardier, High Liner Foods, Vizsla Royalties
July 1 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies including Bombardier, High Liner Foods and Vizsla Royalties on Tuesday.HIGHLIGHTS * Bombardier BBDb.TO: Scotiabank raises to sector outperform from sector perform* High Liner Foods Inc HLF.T...Reuters
Tue, Jul 1
EU approves Vertex's next-generation cystic fibrosis drug
July 1 (Reuters) - Vertex Pharmaceuticals VRTX.O said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a rare and progressive genetic disease, expanding the company’s presence beyond the United States. The approval builds on the company's dominance ...Reuters
Tue, Jul 1
TCDC, New Era Helium’s JV, Signs LOI That Contemplates Land Acquisition And 250MW Power Purchase Agreement
July 1 (Reuters) - New Era Helium Inc NEHC.O:TCDC, NEW ERA HELIUM’S JV, SIGNS LOI WITH LEADING GLOBAL PROVIDER OF HIGH PERFORMANCE CLOUD FOR AI AND MODERN WORKLOADS FOR 250MW AI DATA CENTER JOINT VENTURE IN THE PERMIAN BASINNEW ERA HELIUM INC - LOI CONTEMPLATES LAND ACQUISITION AND 250MW POWER PURCH...Reuters
Tue, Jul 1
Activist Barington asks casket maker Matthews for board seats, warns of second battle
By Svea Herbst-Bayliss NEW YORK, July 1 (Reuters) - Barington Capital Group on Tuesday urged casket maker Matthews International MATW.O to fix its business and immediately invite the activist investor onto its board, or possibly face another clash with the group next year.Barington criticized Mat...Reuters
Tue, Jul 1
Lebanon drafts reply to US demand for Hezbollah to disarm, sources say
U.S. envoy Thomas Barrack visited Beirut on June 19Sources say he presented a roadmap to Lebanese officialsRoadmap contains demands for Hezbollah's disarmamentIn exchange, Israeli troops would withdraw, sources sayBy Laila Bassam and Maya Gebeily BEIRUT, July 1 (Reuters) - Lebanese officials ...Reuters
Tue, Jul 1
GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)
July 1 (Reuters) - GRI Bio Inc GRI.O:GRI BIO COMPLETES ENROLLMENT IN PHASE 2A STUDY OF GRI-0621 FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (“IPF”)GRI BIO INC - TOPLINE RESULTS FROM PHASE 2A STUDY EXPECTED IN Q3 2025GRI BIO INC - GRI-0621 DEMONSTRATED SAFE AND WELL-TOLERATED IN INTERIM SAFETY...Reuters
Tue, Jul 1
